TradingKey

• Investors are recalibrating enterprise IT spending expectations amid macroeconomic uncertainty. • Transition toward cloud-native SASE solutions creates challenges for legacy-heavy cybersecurity providers. • Brokerage firms have lowered price targets due to corporate budget optimization concerns.

• KB Financial Group shares rose following new government Corporate Value-up Program tax incentives. • Resilient net interest margins and strong earnings supported institutional capital inflows into the stock. • The board announced an aggressive share cancellation program and increased dividend payout ratios.

• High demand for Blackwell architecture exceeds current supply chain capacity. • Brokerages raised forecasts due to NVIDIA's expanded software and networking ecosystem. • NVIDIA maintains industry-leading annual revenue of $215.94 billion and net profit.

• ArcelorMittal stock rose due to favorable macroeconomic indicators and increased industrial sector demand. • Stabilizing raw material prices and infrastructure spending expectations are supporting company profit margins. • Debt reduction strategies and green steel initiatives continue attracting institutional investor interest.

• Gilead Sciences shares fell following a failed Phase 3 solid tumor clinical trial. • Strong employment data increased Treasury yields, pressuring biotech sector valuations today. • Analysts may lower earnings forecasts due to delays in oncology portfolio sales timelines.

TradingKey - SK Hynix - WI (SKHYV) opened at $170 in its debut, 14.09% higher than its offering price of $149. Its market capitalization reached $1.27 trillion, currently ranking 11th in the U.S. by market value, below Tesla but above Eli Lilly. Reportedly, when-issued trading was conducted on Friday under the temporary ticker SKHYV, and will officially switch to the regular ticker SKHY next Monday.

TradingKey - On July 10, ET, Marvell Technology (MRVL) shares retreated, falling 3.38% to $235 as of press time. Reportedly, SemiAnalysis founder Dylan Patel stated that the large-scale adoption of co-packaged optics (CPO) may be delayed until late 2028 or 2029. Patel pointed out that current manufacturing yields, chip designs, and supply chain maturity have yet to reach the standards for mass deployment. Furthermore, Nvidia's Rubin and its subsequent Feynman architectures will continue to utilize all-copper solutions, meaning CPO on the GPU side will have to wait for several more generations of chip iterations.

• AstraZeneca shares declined following a failed late-stage oncology trial endpoint. • Increased regulatory scrutiny and pricing pressures have impacted investor sentiment. • Analysts lowered valuations citing execution risks and potential earnings guidance revisions.

• Intel faces delays in manufacturing yield improvements for next-generation foundry processes. • Market share concerns persist in data center and artificial intelligence sectors. • High capital expenditure and interest rates increase institutional selling pressure.

• Elevated interest rates are pressuring Marvell’s high-valuation growth stock. • Concerns over hyperscale custom silicon programs threaten Marvell’s future market share. • Analysts suggest enterprise spending for networking hardware may be plateauing.

• Palo Alto Networks shares declined due to macroeconomic shifts and high interest rate expectations. • Strategic transition toward platformization temporarily suppresses billings growth and concerns institutional investors. • Competition from cloud-native rivals and sector rotation contribute to current stock price volatility.

• Netflix faces subscriber plateau concerns and increased competition in the streaming sector. • Rising interest rates and macro headwinds pressure high-growth technology stock valuations. • Analysts worry that further price increases may elevate subscriber churn rates.

• Vodafone shares rose following regulatory clearance for its telecommunications merger. • Management raised full-year earnings guidance and accelerated debt reduction efforts. • Technical indicators like RSI and Williams %R suggest the stock is oversold.

• Moderna faces downward stock pressure due to revised management guidance on respiratory vaccine revenue. • Concerns regarding late-stage clinical trial timelines and efficacy data have increased investor uncertainty. • The company reported $1.94 billion in annual revenue and a net loss of $2.82 billion.

• Shopify shares rose amid a broader technology sector recovery and resilient retail demand. • AI tool integration enhances merchant retention and streamlines operations for diverse client levels. • Analysts issued multiple buy ratings with an average price target of $149.08.

• Higher interest rates increase capital costs, pressuring Bloom Energy’s project financing and demand. • Analysts lowered revenue projections due to slower adoption of technology in data centers. • Bloom Energy faces execution risks and volatility amid a shift toward defensive stocks.

• Meta released a next-generation large language model with superior performance metrics. • Lower inflation data and potential interest rate cuts boosted investor demand for technology. • Analysts upgraded Meta shares citing improved ad monetization and capital expenditure efficiency.

TradingKey - Tesla’s 480K Q2 deliveries are already priced in. July 22 earnings are about automotive gross margin, Cybercab launch timeline, and whether $25B capex is compressing or expanding future free cash flow. TSLA at $406.

TradingKey - On July 10, Eastern Time, Meta Platforms (META) rose more than 4% at one point in pre-market trading. As of press time, it was trading around $655.45. Meta closed up 4.7% the previous day.

TradingKey - Against the backdrop of record surges in global oil prices and sharply rising industry cost pressures, Delta Air Lines, the most profitable U.S. airline, delivered results that exceeded market expectations.